Future Virology

Towards an effective genital herpes vaccine: past lessons and future prospects
pp. 1-6(6)
Author: Halford, William P

Gastrointestinal immune cells may never recover from HIV attack
pp. 7-9(3)

Abacavir/lamivudine fixed-dose combination tablet for the treatment of HIV-1 infection
pp. 11-21(11)
Authors: Taylor, Clare L; Wilkins, Edmund GL

Fixed-dose combination of abacavir, lamivudine and zidovudine for HIV therapy
pp. 23-30(8)
Authors: Milinkovic, Ana; Mallolas, Josep

Occult hepatitis C and B virus infections in hepatocellular carcinoma
pp. 31-33(3)
Authors: Carreño, Vicente

Advantage of the high genetic diversity in RNA viruses
pp. 35-38(4)
Authors: Biebricher, Christof K; Domingo, Esteban

Pharmacokinetics of experimental antiretroviral agents
pp. 39-48(10)
Authors: Barber, Tristan J; Winston, Alan

Reverse transcription complex: the key player of the early phase of HIV replication
pp. 49-64(16)
Authors: Iordanskiy, Sergey N; Bukrinsky, Michael I

Role of cyclophilin A in HIV replication
pp. 65-78(14)
Authors: Votteler, Jörg; Wray, Victor; Schubert, Ulrich

Future therapy for hepatitis B
pp. 79-90(12)
Authors: Rustgi, Vinod K; Koff, Raymond S

Exploited defense: how influenza viruses take advantage of antiviral signaling responses
pp. 91-100(10)
Author: Ludwig, Stephan

Waterborne norovirus outbreaks
pp. 101-112(12)
Author: Maunula, Leena